A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic Enzymes
Clinical trial NCT07230418 · COMPLETED
Trial details
- NCT number
- NCT07230418
- Sponsor
- Chengdu Suncadia Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-10
- Primary completion
- 2026-04-19
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.